Education
About Us
Working with TipRanks
Follow Us
Bonus Biogroup Ltd. (IL:BONS)
:BONS
Total Valuation
Bonus Biogroup has a market cap or net worth of $249.94M. The enterprise value is ―.
Market Cap$249.94M
Enterprise Value―
Share Statistics
Bonus Biogroup has 1,167,925,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,167,925,300
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bonus Biogroup’s return on equity (ROE) is -4.00 and return on invested capital (ROIC) is -148.00%.
Return on Equity (ROE)-4.00
Return on Assets (ROA)-1.19
Return on Invested Capital (ROIC)-148.00%
Return on Capital Employed (ROCE)-1.80
Revenue Per Employee0.00
Profits Per Employee-567.88K
Employee Count49
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Bonus Biogroup is ―. Bonus Biogroup’s PEG ratio is 1.84.
PE Ratio―
PS Ratio0.00
PB Ratio18.13
Price to Fair Value18.13
Price to FCF-5.81
Price to Operating Cash Flow-8.17
PEG Ratio1.84
Income Statement
In the last 12 months, Bonus Biogroup had revenue of 0.00 and earned -27.83M in profits. Earnings per share was -0.02.
Revenue0.00
Gross Profit-2.79M
Operating Income-27.84M
Pretax Income-27.83M
Net Income-27.83M
EBITDA-26.20M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -18.30M and capital expenditures -82.00K, giving a free cash flow of -18.38M billion.
Operating Cash Flow-18.30M
Free Cash Flow-18.38M
Free Cash Flow per Share-0.02
Dividends & Yields
Bonus Biogroup pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.09
52-Week Price Change76.86%
50-Day Moving Average23.99
200-Day Moving Average20.70
Relative Strength Index (RSI)37.06
Average Volume (3m)1.16M
Important Dates
Bonus Biogroup upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Bonus Biogroup as a current ratio of 0.91, with Debt / Equity ratio of -573.31%
Current Ratio0.91
Quick Ratio0.91
Debt to Market Cap0.01
Net Debt to EBITDA-0.13
Interest Coverage Ratio-34.93
Taxes
In the past 12 months, Bonus Biogroup has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Bonus Biogroup EV to EBITDA ratio is -4.94, with an EV/FCF ratio of -5.96.
EV to Sales0.00
EV to EBITDA-4.94
EV to Free Cash Flow-5.96
EV to Operating Cash Flow-6.06
Balance Sheet
Bonus Biogroup has $1.20M in cash and marketable securities with $9.60M in debt, giving a net cash position of -$8.41M billion.
Cash & Marketable Securities$1.20M
Total Debt$9.60M
Net Cash-$8.41M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Bonus Biogroup is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―